GLENMARK PHARMACEUTICALS LTD. - 532296 - Company''s Aurangabad Facility Receives Establishment Inspection Report
Company''s Aurangabad Facility receives Establishment Inspection Report (EIR)22-09-2022
22-09-2022
GLENMARK PHARMACEUTICALS LTD. - 532296 - Update On The Company''s Baddi (India) Facility
Update on the Company''s Baddi (India) Facility22-09-2022
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor Meeting07-09-2022
Glenmark Pharma launches Ryaltris nasal spray for allergic rhintis in US
British drugmaker Hikma to distribute Ryaltris while Glenmark will manufacture it31-08-2022
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Hikma launches RVALTRIS(tm) seasonal allergic rhinitis nasal spray in the US30-08-2022
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith copies of newspaper advertisement published in Financial Express (English) and Loksatta (Marathi) which includes the following information: Intimation of 44th AGM of the Company to be held through video conferencing / other audio-visual means and confirmation of email dispatch of Notice of AGM and Annual Report for the Financial Year 2021-22. Particulars of the facility of e-voting provided to Shareholders of the Company, to enable them to cast their votes on the resolutions proposed to be passed at the AGM. Details of Book Closure for the purpose of determining members who would be entitled to dividend if declared, at the AGM.29-08-2022
GLENMARK PHARMACEUTICALS LTD. - 532296 - Update On The Company''s Goa (India) Facility
Update on the Company''s Goa (India) Facility27-08-2022
GLENMARK PHARMACEUTICALS LTD. - 532296 - Reg. 34 (1) Annual Report.
Submission of Annual Report under Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201527-08-2022
GLENMARK PHARMACEUTICALS LTD. - 532296 - Notice Of 44Th Annual General Meeting Of The Company For F.Y. 2021-22
Further to our letter dated August 24, 2022 and pursuant to Regulation 30 of the Listing Regulations, enclosed please find herewith the Notice and Explanatory statement Convening the 44th Annual General Meeting (AGM) scheduled to be held on Tuesday, September 27, 2022 at 2.00 p.m. IST through Video Conferencing {VC) / Other Audio-Visual Means (OAVM). The notice of AGM is being sent to all the members whose email Ids have been registered with the Company. The Company is pleased to provide to its members the facility to exercise their right to vote on the resolutions proposed to be passed at the AGM by electronic means. Only Shareholders, whose name is recorded in the register of members or in the register of beneficial owners maintained by the depositories as on the cut-off date, i.e. Tuesday, September 20, 2022, shall be entitled to avail thee-voting facility.27-08-2022
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, enclosed are the copies of newspaper advertisement informing the Members about the 44th Annual General Meeting scheduled to be held on Tuesday, September 27, 2022 at 2:00 p.m. 1ST through Video Conferencing (VC) / Other Audio Visual Means (OAVM), as published in Financial Express (English) all India edition and Navshakti (Marathi) Maharashtra edition today i.e. on August 26, 2022.26-08-2022